Related Experiment Video
Updated: Feb 3, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers
William P Harris1, Kit Man Wong1, Supriya Saha2
1Department of Medicine, Division of Medical Oncology, University of Washington, Seattle WA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle WA.
Abstract:
The recent accumulation of molecular profiling data for primary hepatobiliary malignancies, including hepatocellular carcinoma and biliary tract cancers, has led to a proliferation of promising therapeutic investigations in recent years. Treatment with pathway-specific targeted inhibitors and immunotherapeutic agents have demonstrated promising early clinical results. Key molecular alterations in common hepatobiliary cancers and ongoing interventional clinical trials of molecularly targeted systemic agents focusing on hepatocellular carcinoma and biliary tract cancer are reviewed.
Insights
Molecular profiling data is advancing treatments for liver and bile duct cancers. Targeted therapies and immunotherapies show early promise in clinical trials for these hepatobiliary malignancies.
Area of Science:
- Oncology
- Molecular Biology
- Hepatobiliary Medicine
Background:
- Molecular profiling of hepatobiliary malignancies has rapidly expanded.
- Hepatocellular carcinoma and biliary tract cancers are significant health concerns.
Purpose of the Study:
- To review key molecular alterations in common hepatobiliary cancers.
- To summarize ongoing clinical trials for targeted systemic agents in these cancers.
Main Methods:
- Review of recent molecular profiling data.
- Analysis of published and ongoing clinical trial data.
Main Results:
- Targeted inhibitors and immunotherapeutic agents show promising early clinical results.
- Identification of key molecular targets in hepatocellular carcinoma and biliary tract cancers.
Conclusions:
- Molecularly targeted therapies represent a promising new avenue for hepatobiliary cancer treatment.
- Ongoing clinical trials are crucial for advancing systemic therapy options.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Gene Therapy
Molecular Models
Molecular Orbital Theory II
Molecular Orbital Theory I

